الفهرس 
Aim of the workOnly 14 pages are availabe for public view
 |  | from | 113 |  |  |
| | | from | 113 | | |
Abstract
COVID-19 or coronavirus disease 2019 is viral infection caused by coronavirus.
The most common neurological manifestations in COVID-19 patients include headache, confusion, dizziness, mild cognitive impairment, altered taste, loss of smell, blurred vision and neurologic disorder such as stroke, Guillain-Barre syndrome, encephalopathy, and many more.
Several neurological and neuroradiological phenotypes have been observed in patients with COVID-19.
The study is aimed to describe any neurological complication of definite covid-19 infection patients and its relation with the onset and evolution of the infection.
This study is multi-center observational cross sectional study. Data was obtained from the archived files of the selected Covid-19 patients, in addition to patient who admitted at Isolated ICU and inpatient rooms at Menoufia university hospitals, Shebin el-kom teaching hospital, El-bajur general hospital, Menouf general hospital and Sirs-ellian general hospital. The duration of the recruiting period will be 6months.
The main results of the study revealed that:
The presence of neurological complications was significantly associated with female gender (25.8 vs 15.9%), presence of comorbidities (40.2 vs 9.2%), hypertension (53.6 vs 20.5%), DM (44.3 vs 11.3%), HCV (7.2 vs 0.5%), and history of CVS (7 vs 0%).
The significant predictors for developing the neurological manifestations are female sex, DM, any comorbidity.